Autonomix Medical, Inc.
AMIX
$5.37
$0.101.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.32M | 9.89M | 10.31M | 10.40M | 6.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.38M | 17.04M | 17.55M | 16.95M | 12.26M |
| Operating Income | -16.38M | -17.04M | -17.55M | -16.95M | -12.26M |
| Income Before Tax | -16.11M | -16.72M | -17.24M | -16.69M | -12.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.11 | -16.72 | -17.24 | -16.69 | -12.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.11M | -16.72M | -17.24M | -16.69M | -12.05M |
| EBIT | -16.38M | -17.04M | -17.55M | -16.95M | -12.26M |
| EBITDA | -16.37M | -17.02M | -17.49M | -16.85M | -12.11M |
| EPS Basic | -46.51 | -64.18 | -83.60 | -106.71 | -125.55 |
| Normalized Basic EPS | -29.07 | -40.11 | -52.25 | -66.69 | -78.47 |
| EPS Diluted | -46.51 | -64.18 | -83.60 | -106.71 | -125.55 |
| Normalized Diluted EPS | -29.07 | -40.11 | -52.25 | -66.69 | -78.47 |
| Average Basic Shares Outstanding | 1.77M | 1.37M | 962.30K | 624.00K | 425.10K |
| Average Diluted Shares Outstanding | 1.77M | 1.37M | 962.30K | 624.00K | 425.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |